Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
23 Leser
Artikel bewerten:
(0)

Des Hague of Hague Enterprises Joins Launch of SurgiStrong RecoverAid

SurgiStrong RecoverAid™ is a pre-surgery beverage designed to aid recovery

DENVER, CO / ACCESSWIRE / December 18, 2017 / Des Hague, Co-Founder and CEO of Hague Enterprises, announced today the US launch of SurgiStrong RecoverAid™, a beverage that has been developed for surgery patients to drink prior to surgery. It supplies the body with vital nutrition and hydration needed for an efficient successful recovery. This beverage was developed in response to new research showing that the body heals faster when it has been pre-loaded with specific nutrients.

"We are always looking for breakthrough products that either do good for the body, the environment and/or community and SurgiStrong RecoverAid fits this bill," said Hague and added, "SurgiStrong RecoverAid is a product that has the potential to aid in the pre- and post-operation recovery globally of over two hundred million patients annually. The benefit to the patients, the healthcare system and hospitals will be extraordinary. We are thrilled to get involved and help Dr. Trotter and the team realize this potential."

"We are at the forefront of a new industry, the surgery-specific nutritional products industry, and we are delighted that Mr. Hague has agreed to join us to accomplish our guiding principle: To pioneer products and services that will improve the lives of surgical patients worldwide," stated SurgiStrong Chief Executive Officer/Founder Siobhan M. Trotter, DNP, APRN, AGNP-C (Dr. Trotter). "Mr. Hague is an internationally well-regarded trailblazer in the food and beverage industry, and his skills and dynamism combined with our mutual vision will enable us to accomplish the dream of improving surgical patient's lives across the globe," she concluded.

About SurgiStrong RecoverAid™

SurgiStrong RecoverAid™ is an easily digestible, complex carbohydrate beverage that has been designed to be ingested by patients in preparation for surgery. It is compliant with current research recommendations, all U.S. major surgical and anesthesia guidelines, and enhanced recovery before surgery guidelines. It contains key electrolytes (sodium and potassium), is a good source of Antioxidant Vitamins A and C, is an excellent source of Vitamin D, and contains amino acid L-Citrulline. SurgiStrong RecoverAid™ is great tasting with a clean finish (no aftertaste) and is made with quality ingredients. There are no artificial ingredients, no artificial sweeteners or artificial preservatives, dyes or unnecessary additives, and it adheres to the highest manufacturing standards. The drink is shelf-stable for 12 months, and the product has been rigorously tested for stability in both ingredient and vitamin integrity throughout the best before and use by dates. There is a patent pending on SurgiStrong RecoverAid™. For more information: www.SurgiStrong.com.

About Hague Enterprises

Hague Enterprises, LLC. is a Colorado-based advisory and investment company focused on multiple sectors. The firm provides business advisory services, expansion, start-up and turn-around venture capital investment opportunities, executive mentorship, consulting and leadership development programs led by the firm's preeminent business thought leaders.

For more information: www.deshague.com and www.deshaguenews.com.

Des Hague - https://www.linkedin.com/in/deshague/, https://www.crunchbase.com/organization/aegis-enterprises-llc#/entity.

CONTACT INFORMATION

Hague Enterprises

http://www.HagueEnterprises.com

deshague@aegisenterprisesllc.com

SOURCE: Hague Enterprises


© 2017 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.